The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

The nonprofit Physicians Committee for Responsible Medicine, which promotes the use of human-relevant test methods to replace ...

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

Pfizer has stopped the development of its weight loss pill after a patient experienced a liver injury that was potentially ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...

CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...